News Conference News HFSA 2024 Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM By L.A. McKeown October 04, 2024
News Conference News HFSA 2024 EXPANDed: Atrial Secondary MR Patients Get Clinical Benefit From TEER By Caitlin E. Cox October 03, 2024
News Conference News HFSA 2024 ‘Metabolic Accelerator’ Cuts Weight, Not Muscle in HFpEF: HuMAIN-HF By Michael O'Riordan October 03, 2024
News Conference News HFSA 2024 ‘Global Efficacy’ of Aficamten for Obstructive Disease Shown in SEQUOIA-HCM By L.A. McKeown October 02, 2024
News Conference News HFSA 2024 FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone? By Michael O'Riordan October 02, 2024
News Conference News HFSA 2024 Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity By Todd Neale October 01, 2024
News Conference News ESC 2024 ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions By Michael O'Riordan September 17, 2024
News Conference News ESC 2024 Endometriosis and CV Risk: Link Needs Further Attention and Research By Yael L. Maxwell September 12, 2024
News Conference News ESC 2024 AI Tool Fails to Boost Outcomes in ED Triage of Suspected CV Conditions By Caitlin E. Cox September 12, 2024
News Conference News ESC 2024 More Support for Ticagrelor Monotherapy After PCI, Especially in ACS By Yael L. Maxwell September 10, 2024